On the public citation graph
Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges
0 signed · 122 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamaoncol.2021.1962openalex-snapshot
Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2021.2155openalex-snapshot
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2021.2675openalex-snapshot
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2022.0752openalex-snapshot
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant
inferredcites →https://doi.org/10.1002/emmm.201100165openalex-snapshot
PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8+ T cells
inferredcites →https://doi.org/10.1002/jmv.27599openalex-snapshot
Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review
inferredcites →https://doi.org/10.1007/s00259-011-1729-9openalex-snapshot
Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination
inferredcites →https://doi.org/10.1007/s00259-021-05278-3openalex-snapshot
COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma
inferredcites →https://doi.org/10.1007/s00259-021-05314-2openalex-snapshot
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation
inferredcites →https://doi.org/10.1007/s00262-021-03133-wopenalex-snapshot
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
inferredcites →https://doi.org/10.1007/s00432-022-03961-yopenalex-snapshot
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey
inferredcites →https://doi.org/10.1007/s00520-021-06419-yopenalex-snapshot
Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients
inferredcites →https://doi.org/10.1007/s10549-021-06293-6openalex-snapshot
COVID-19 vaccination and breast cancer surgery timing
inferredcites →https://doi.org/10.1007/s11060-021-03911-7openalex-snapshot
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
inferredcites →https://doi.org/10.1007/s12029-017-9930-0openalex-snapshot
Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review
inferredcites →https://doi.org/10.1007/s12032-021-01553-3openalex-snapshot
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
inferredcites →https://doi.org/10.1007/s12149-011-0568-xopenalex-snapshot
Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination
inferredcites →https://doi.org/10.1016/j.acra.2022.02.015openalex-snapshot
Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy
inferredcites →https://doi.org/10.1016/j.annonc.2021.09.009openalex-snapshot
Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study
inferredcites →https://doi.org/10.1016/j.annonc.2021.12.001openalex-snapshot
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
inferredcites →https://doi.org/10.1016/j.breast.2021.10.012openalex-snapshot
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective
inferredcites →https://doi.org/10.1016/j.ccell.2021.06.002openalex-snapshot
Seroconversion rates following COVID-19 vaccination among patients with cancer
inferredcites →https://doi.org/10.1016/j.ccell.2021.06.009openalex-snapshot
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
inferredcites →https://doi.org/10.1016/j.ccell.2021.11.006openalex-snapshot
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
inferredcites →https://doi.org/10.1016/j.clinimag.2021.07.015openalex-snapshot
Mammographic and sonographic findings in the breast and axillary tail following a COVID-19 vaccine
inferredcites →https://doi.org/10.1016/j.devcel.2020.05.012openalex-snapshot
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
inferredcites →https://doi.org/10.1016/j.ejca.2021.06.023openalex-snapshot
Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study
inferredcites →https://doi.org/10.1016/j.ejca.2021.08.035openalex-snapshot
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy
inferredcites →https://doi.org/10.1016/j.ejca.2021.10.013openalex-snapshot
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
inferredcites →https://doi.org/10.1016/j.ejca.2022.02.017openalex-snapshot
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments
inferredcites →https://doi.org/10.1016/j.ejca.2022.03.013openalex-snapshot
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours
inferredcites →https://doi.org/10.1016/j.esmoop.2021.100272openalex-snapshot
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
inferredcites →https://doi.org/10.1016/j.esmoop.2021.100274openalex-snapshot
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
inferredcites →https://doi.org/10.1016/j.esmoop.2021.100283openalex-snapshot
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment
inferredcites →https://doi.org/10.1016/j.esmoop.2021.100350openalex-snapshot
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study
inferredcites →https://doi.org/10.1016/j.esmoop.2021.100359openalex-snapshot
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
inferredcites →https://doi.org/10.1016/j.ijrobp.2021.02.048openalex-snapshot
COVID-19 Vaccine-Induced Radiation Recall Phenomenon
inferredcites →https://doi.org/10.1016/j.immuni.2007.05.016openalex-snapshot
Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
inferredcites →https://doi.org/10.1016/j.it.2015.06.004openalex-snapshot
Engineering CAR-T cells: Design concepts
inferredcites →https://doi.org/10.1016/j.jacr.2021.03.001openalex-snapshot
Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties
inferredcites →https://doi.org/10.1016/j.jiac.2021.12.021openalex-snapshot
Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
inferredcites →https://doi.org/10.1016/j.molonc.2012.02.003openalex-snapshot
Hormonal therapy in breast cancer: A model disease for the personalization of cancer care
inferredcites →https://doi.org/10.1016/j.mpmed.2007.10.012openalex-snapshot
Cytotoxic chemotherapy: clinical aspects
inferredcites →https://doi.org/10.1016/j.radonc.2021.11.012openalex-snapshot
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
inferredcites →https://doi.org/10.1016/s0140-6736(09)60237-3openalex-snapshot
Graft-versus-host disease
inferredcites →https://doi.org/10.1016/s0377-1237(10)80132-7openalex-snapshot
Radiotherapy: Basic Concepts and Recent Advances
inferredcites →https://doi.org/10.1016/s1470-2045(21)00155-8openalex-snapshot
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
inferredcites →https://doi.org/10.1016/s1470-2045(21)00213-8openalex-snapshot
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
inferredcites →https://doi.org/10.1016/s1470-2045(21)00427-7openalex-snapshot
Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy
inferredcites →https://doi.org/10.1038/nrc3239openalex-snapshot
The blockade of immune checkpoints in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nri2216openalex-snapshot
Immunological aspects of cancer chemotherapy
inferredcites →https://doi.org/10.1038/s41408-021-00459-7openalex-snapshot
CAR-T cell therapy: current limitations and potential strategies
inferredcites →https://doi.org/10.1038/s41586-020-2008-3openalex-snapshot
A new coronavirus associated with human respiratory disease in China
inferredcites →https://doi.org/10.1038/s41591-021-01387-6openalex-snapshot
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
inferredcites →https://doi.org/10.1038/s41591-021-01542-zopenalex-snapshot
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
inferredcites →https://doi.org/10.1038/s43018-021-00274-wopenalex-snapshot
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
inferredcites →https://doi.org/10.1038/s43018-022-00364-3openalex-snapshot
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
inferredcites →https://doi.org/10.1080/00207454.2022.2050907openalex-snapshot
A case report of longitudinal extensive transverse myelitis: immunotherapy related adverse effect vs. COVID-19 related immunization complications
inferredcites →https://doi.org/10.1080/07357907.2021.1992420openalex-snapshot
Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
inferredcites →https://doi.org/10.1080/21645515.2021.1943988openalex-snapshot
COVID-19 vaccine development from the perspective of cancer patients
inferredcites →https://doi.org/10.1093/jnci/djab174openalex-snapshot
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients
inferredcites →https://doi.org/10.1093/ofid/ofab353openalex-snapshot
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
inferredcites →https://doi.org/10.1097/md.0000000000028561openalex-snapshot
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options
inferredcites →https://doi.org/10.1097/rlu.0000000000003648openalex-snapshot
Axillary Lymph Nodes Hypermetabolism After BNT162b2 mRNA COVID-19 Vaccination in Cancer Patients Undergoing 18F-FDG PET/CT
inferredcites →https://doi.org/10.1136/jitc-2021-003712openalex-snapshot
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
inferredcites →https://doi.org/10.1136/jitc-2021-004157openalex-snapshot
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study
inferredcites →https://doi.org/10.1148/radiol.2021210436openalex-snapshot
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel
inferredcites →https://doi.org/10.1152/physrev.00018.2020openalex-snapshot
Immunometabolic Status of COVID-19 Cancer Patients
inferredcites →https://doi.org/10.1158/0008-5472.can-21-3554openalex-snapshot
Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-21-2439openalex-snapshot
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1177/03000605221086155openalex-snapshot
COVID-19 vaccination in cancer patients: a narrative review
inferredcites →https://doi.org/10.1182/blood.2021011568openalex-snapshot
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
inferredcites →https://doi.org/10.1186/s13027-022-00419-1openalex-snapshot
Not only lymphadenopathy: case of chest lymphangitis assessed with MRI after COVID 19 vaccine
inferredcites →https://doi.org/10.1186/s13045-021-01046-wopenalex-snapshot
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
inferredcites →https://doi.org/10.1186/s13045-021-01090-6openalex-snapshot
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
inferredcites →https://doi.org/10.1200/jco.21.01891openalex-snapshot
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
inferredcites →https://doi.org/10.1212/wnl.98.18_supplement.1542openalex-snapshot
Longitudinal Extensive Transverse Myelitis: rare immunotherapy related adverse effect vs COVID-19-related immunization complication (P1-1.Virtual)
inferredcites →https://doi.org/10.12659/msm.932788openalex-snapshot
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology Clinic of University Clinical Hospital Mostar, Bosnia and Herzegovina: A Cross-Sectional Study
inferredcites →https://doi.org/10.17219/acem/138962openalex-snapshot
Cancer patients and internal medicine patients attitude towards COVID-19 vaccination in Poland
inferredcites →https://doi.org/10.20892/j.issn.2095-3941.2020.0289openalex-snapshot
COVID-19 in cancer patients: risk, clinical features, and management
inferredcites →https://doi.org/10.21873/anticanres.15692openalex-snapshot
Influence of the Coronavirus Disease 2019 Vaccine on Drug Therapy for Urological Cancer
inferredcites →https://doi.org/10.2196/29872openalex-snapshot
COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey
inferredcites →https://doi.org/10.2214/ajr.21.25728openalex-snapshot
COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management
inferredcites →https://doi.org/10.2217/fon-2021-0265openalex-snapshot
Perceptions of the COVID-19 vaccine Among Patients With Cancer: A Single-Institution Survey
inferredcites →https://doi.org/10.2217/fon-2021-1015openalex-snapshot
Impact of Corona-Phobia on Attitudes and Acceptance Towards COVID-19 Vaccine Among Cancer Patients: a Single-Center Study
inferredcites →https://doi.org/10.2217/fon-2021-1248openalex-snapshot
Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study
inferredcites →https://doi.org/10.2217/fvl-2021-0166openalex-snapshot
mRNA-based COVID-19 Vaccines Appear to not Increase Immune Events in Cancer Patients Receiving Immune Checkpoint Inhibitors
inferredcites →https://doi.org/10.2217/imt-2021-0235openalex-snapshot
The Mrna Covid-19 Vaccine In Patients with Cancer Receiving Checkpoint Inhibitor Therapy: What we Know And What We Don’T
inferredcites →https://doi.org/10.2967/jnumed.121.262194openalex-snapshot
COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake
inferredcites →https://doi.org/10.31557/apjcp.2021.22.11.3499openalex-snapshot
COVID-19 Vaccination Acceptance and Its Associated Factors among Cancer Patients in Tunisia
inferredcites →https://doi.org/10.3348/kjr.2021.0350openalex-snapshot
COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT
inferredcites →https://doi.org/10.3389/fendo.2022.798975openalex-snapshot
A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
inferredcites →https://doi.org/10.3389/fmed.2021.741204openalex-snapshot
Prevalence and Impact Factors of COVID-19 Vaccination Hesitancy Among Breast Cancer Survivors: A Multicenter Cross-Sectional Study in China
inferredcites →https://doi.org/10.3390/biology10030214openalex-snapshot
Lymphadenopathy after BNT162b2 Covid-19 Vaccine: Preliminary Ultrasound Findings
inferredcites →https://doi.org/10.3390/cancers13143573openalex-snapshot
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
inferredcites →https://doi.org/10.3390/cancers13153883openalex-snapshot
Cancer Patients’ Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea
inferredcites →https://doi.org/10.3390/cancers13164191openalex-snapshot
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
inferredcites →https://doi.org/10.3390/cancers13174312openalex-snapshot
Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients
inferredcites →https://doi.org/10.3390/vaccines10010012openalex-snapshot
Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
inferredcites →https://doi.org/10.3390/vaccines10020164openalex-snapshot
COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety
inferredcites →https://doi.org/10.3390/vaccines10040618openalex-snapshot
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
inferredcites →https://doi.org/10.3390/vaccines9070792openalex-snapshot
Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate
inferredcites →https://doi.org/10.4048/jbc.2022.25.e12openalex-snapshot
Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
inferredcites →https://doi.org/10.4414/smw.2021.20557openalex-snapshot
Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy
inferredcites →https://doi.org/10.6004/jnccn.2021.7113openalex-snapshot
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine
inferredcites →https://doi.org/10.7759/cureus.13524openalex-snapshot
Lymphadenopathy Associated With the COVID-19 Vaccine
inferredcites →https://doi.org/10.7759/cureus.21499openalex-snapshot
Breast Radiation Recall Phenomenon After Astra-Zeneca COVID-19 Vaccine: A Case Series
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4632955openalex-extracted
Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients
inferred← citeshttps://doi.org/10.1007/978-981-95-8026-2_11openalex-snapshot
Immune Checkpoints and COVID-19: Insights Into Immunopathogenesis, Therapeutic Opportunities, and Vaccine Implications
inferred← citeshttps://doi.org/10.1007/s00520-025-10222-4openalex-snapshot
Radiation recall dermatitis in cancer patients previously undergoing radiotherapy: a scoping review
inferred← citeshttps://doi.org/10.1016/j.bbadis.2024.167563openalex-snapshot
Linking COVID-19 and cancer: Underlying mechanism
inferred← citeshttps://doi.org/10.1016/j.jds.2024.06.020openalex-snapshot
COVID-19 vaccination patterns among oral cancer patients: A comprehensive analysis in a medical center in Taiwan
inferred← citeshttps://doi.org/10.1093/infdis/jiad174openalex-snapshot
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
inferred← citeshttps://doi.org/10.1186/s13027-025-00654-2openalex-snapshot
Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy
inferred← citeshttps://doi.org/10.29228/jrp.544openalex-snapshot
COVID-19 vaccine-related pathologies: cardiac and neurological side effects and Long-term COVID-19
inferred← citeshttps://doi.org/10.3389/fmed.2024.1325478openalex-snapshot
Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review
inferred← citeshttps://doi.org/10.3390/cancers15061771openalex-snapshot
Perspectives and Challenges of COVID-19 with Obesity-Related Cancers
inferred← citeshttps://doi.org/10.3390/cancers15123115openalex-snapshot
Insights into the Impact of Hesitancy on Cancer Care and COVID-19
inferred← citeshttps://doi.org/10.3390/vaccines13121223openalex-snapshot
Assessing COVID-19 Infection and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern Italy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.